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Abstract 
Purpose:  High digestible carbohydrate intakes can induce hyperglycemia and hyperinsulinemia, and collectively 
have been implicated in colorectal tumor development.  Our aim was to explore the association between aspects 
of dietary carbohydrate intake and risk of colorectal adenomas and hyperplastic polyps in a large case-control 
study.  
Methods:  Colorectal polyp cases (n=1,315 adenomas only, n=566 hyperplastic polyps only and n=394 both) and 
controls (n=3,184) undergoing colonoscopy were recruited between 2003 and 2010 in Tennessee, USA.  Dietary 
intakes were estimated by a 108-item food frequency questionnaire.  Unconditional logistic regression analysis 
was applied to determine odds ratios (OR) and corresponding 95% confidence intervals (CI) for colorectal polyps 
according to dietary carbohydrate intakes, after adjustment for potential confounders.   
Results:  No significant associations were detected for risk of colorectal adenomas when comparing the highest 
versus lowest quartiles of intake for total sugars (OR 1.03; 95% CI 0.84-1.26), starch (OR 1.01; 95% CI 0.81-
1.26), total or available carbohydrate intakes.  Similar null associations were observed between dietary 
carbohydrate intakes and risk of hyperplastic polyps, or concurrent adenomas and hyperplastic polyps. 
Conclusion:  In this US population, digestible carbohydrate intakes were not associated with risk of colorectal 
polyps, suggesting that dietary carbohydrate does not have an etiological role in the early stages of colorectal 
carcinogenesis. 
 
Keywords: diet; carbohydrate; starch; sugars; colorectal adenomas; hyperplastic polyps; colorectal polyps. 
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Introduction 
Elevated circulating insulin and glucose levels have been strongly associated with colonic carcinogenesis, and an 
increased risk of colorectal adenomas [1, 2].  Hyperglycemia may induce chronic inflammation and tissue damage 
via excess oxidative stress and the liberation of pro-inflammatory cytokines, both of which may be implicated in 
carcinogenesis [3, 4].  In addition, meta-analyses have illustrated that colorectal cancer risk is positively associated 
with high levels of circulating insulin and C-peptide, a marker of insulin secretion [5].  Insulin itself conveys 
mitogenic properties in vitro that promote tumor cell growth but also acting indirectly through the actions of 
insulin-like growth factors (IGFs) and associated binding proteins [6].  Two comprehensive systematic reviews 
have identified a direct association between circulating IGF-1 concentrations and risk of colorectal cancer [7, 8]. 
 
Digestible carbohydrate intakes are a key determinant of blood glucose and insulin responses, therefore, it is 
plausible that available carbohydrate intakes may be related to colorectal cancer and polyp risk [2, 9].   Despite 
the biological mechanisms potentially linking available carbohydrate, i.e. sugars and starch, intakes with 
colorectal neoplasm development, relatively few studies have examined this relationship.  Indeed, the World 
Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Continuous Update Project report 
on colorectal cancer published in 2011 was unable to make a ‘convincing’ or ‘probable’ judgement on the 
association between digestible carbohydrate intakes and colorectal cancer risk [10].  This has led to calls for 
further research on starch, sugars and colorectal health in order to provide clarification of the relationship and 
make appropriate public health recommendations [11].   
 
To our knowledge, only one prior study has explored the role of dietary carbohydrate on risk of colorectal polyps 
[12].  In that study, conducted within the US Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening 
trial, the highest intakes of dietary carbohydrate was associated with a 29% reduced risk of adenoma in men, but 
this was not seen in women [12].  Further, the risk of adenoma according to sugars and starch intake separately 
was not investigated in the PLCO analysis.  Previous research from our group has demonstrated that well-
established lifestyle factors for colorectal cancer can also influence risk of pre-malignant adenoma and 
hyperplastic polyp development [13].  Therefore, our aim was to explore the association between aspects of dietary 
carbohydrate intake and risk of colorectal adenomas and hyperplastic polyps in a large case-control study.  
 
Materials and Methods 
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Study design 
The Tennessee Colorectal Polyp Study is a case-control study conducted in Nashville, Tennessee, USA. A detailed 
study design has been described elsewhere [14].  Briefly, eligible participants aged 40-75 years were recruited 
from patients undergoing colonoscopy at the Vanderbilt Gastroenterology Clinic between February 2003 and 
October 2010, and the Veterans Affairs Tennessee Valley Health System Nashville Campus between August 2003 
and May 2007.  Individuals were excluded if they had genetic colorectal cancer syndromes, a prior history of 
inflammatory bowel disease, adenomatous polyps, or cancer (except non-melanoma skin cancer).  The study was 
approved by the Vanderbilt University Institutional Review Board, the Veterans Affairs Institutional Review 
Board, and the Veterans Affairs Research and Development Committee.   
 
Study participants 
Among 12,585 eligible individuals, 7,621 participated (61% response rate).  Following colonoscopy and 
pathology review, 7,487 participants were classified as polyp-free controls (who had a complete colonoscopy 
reaching the cecum), or cases with adenomas(s) only, hyperplastic polyp(s) only, or both.   
 
Data collection 
Standardized telephone interviews following colonoscopy were conducted to collect information on 
demographics, medication use, medical history, family history, reproductive factors, anthropometry and lifestyle.  
Dietary intake was assessed using a semi-quantitative 108-item food frequency questionnaire (FFQ), developed 
to capture diet in the Southeastern US [15, 16].  Among participants, 5,495 (73%) completed both the telephone 
interview and FFQ.  Telephone interview and FFQ responders did not differ from non-responders with regards to 
most characteristics, including case-control status, sex, smoking (pack-years) or exercise undertaken in the past 
10 years, after accounting for study site.  Telephone interview and FFQ responders were, on average 2-3 years 
older than non-responders. 
 
Statistical analysis 
Participants were excluded from analysis if they had daily energy intakes ≤600 kcal/day (n=36).  Available 
carbohydrate intake was derived by subtracting dietary fiber from total carbohydrate intakes. Analysis of total 
sugars intake represents the sum of all monosaccharides and disaccharides, in accordance with standard 
classifications [17]. 
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Characteristics and mean nutrient intakes were compared between groups using general linear models and Mantel-
Haenszel chi-squared tests with additional adjustment for age and sex when appropriate.  Unconditional logistic 
regression analysis was conducted to generate odds ratios (OR) and corresponding 95% confidence intervals (CI) 
for polyps, according to quartiles of intake.  Multivariate analyses were adjusted for energy intake (via the 
residuals method [18]), age, sex, study site, colonoscopy indication, race, BMI, smoking status, alcohol 
consumption, exercise and intakes of red meat, calcium and dietary folate equivalents.  Other potential 
confounders outlined in Table 1 were not significantly associated with both intake and case status.  Quartiles of 
carbohydrate intake were entered into regression models as continuous variables to test for trend.  Statistical power 
calculations are shown in Table 2. 
 
Sub-group analyses were conducted, grouping individuals with any adenoma diagnosis (with or without a 
concurrent hyperplastic polyp), and by number of adenomas, location of adenomas, advanced adenomas, sessile 
serrated adenomas, sex, BMI categories, smoking status, multivitamin use and prior history of hyperplastic polyps.  
All statistical analysis was performed using SAS version 9.3 (SAS Institute, Cary, North Carolina, USA).  
 
Results 
Descriptive characteristics and daily nutrient intakes for all case groups and controls are shown in Table 1.  All 
polyp cases were more likely to be male, smoke tobacco, consume alcohol, and were less likely to take 
multivitamins or regular exercise compared with controls.  Adenoma, but not hyperplastic polyp, cases were older, 
less likely to be White or use non-steroidal anti-inflammatory drugs, and had higher BMIs compared with controls. 
 
In fully adjusted models, no associations were identified for risk of colorectal adenomas when comparing the 
highest versus lowest quartiles of intake for total sugars (OR 1.03; 95% CI 0.84-1.26), starch (OR 1.01; 95% CI 
0.81-1.26), total or available carbohydrate intakes (Table 2).  Similarly, total carbohydrate, available carbohydrate, 
total sugars and starch intakes were not found to be related to risk of hyperplastic polyps.  A non-significant 
reduced risk of concurrent adenomas and hyperplastic polyps was observed for individuals consuming the highest 
compared with the lowest intakes of starch (OR 0.73, 95%CI 0.49-1.08).  Adjustment for dietary folate equivalents 
was the main confounder attenuating the relationship between starch and polyp risk.  The null associations 
observed did not differ for risk of any adenoma, multiple adenomas, advanced adenomas, distal adenomas, 
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proximal adenomas, sessile serrated adenomas, sex, by multivitamin use, BMI categories or smoking status, or 
among individuals with no prior history of non-adenomatous polyps (data not shown). 
  
 
Discussion 
In this US population, no significant associations were detected between aspects of digestible dietary carbohydrate 
intake and colorectal adenoma or hyperplastic polyp risk.   
 
Our results are the first to report on the association between these dietary exposures and hyperplastic polyp or 
sessile serrated adenoma risks, and this study is among the largest to report on colorectal adenoma risk.   Our 
findings contrast with a previous report from the US PLCO cancer screening trial, which identified an inverse 
association between available carbohydrate intake and prevalent colorectal adenoma risk in men, but not women 
[12].  The lack of an association between digestible carbohydrate intake and colorectal polyp risk is perhaps 
surprising, since one of the main hypothesised mechanisms for this association is via hyperinsulinaemia, markers 
of which have been strongly linked with elevated colon cancer risk [5, 6].  However, glycemic index and glycemic 
load, which are alternative concepts to quantify the impact of carbohydrate-foods on postprandial glucose 
responses [19], have also been shown to be unrelated to colorectal cancer and adenoma risk in a systematic review 
[20].  Moreover, a recent US case-control study documented an unexpected inverse association between IGF-1 
receptor levels and colorectal adenoma risk [21], thereby conflicting with earlier evidence of a direct association 
with colorectal cancer risk [7]. Collectively, the biological and epidemiological evidence to date appear to be 
contrasting.  A global report could only determine that there is limited suggestive evidence that foods containing 
sugars increase colorectal cancer risk, while the association with other aspects of digestible carbohydrate intake 
remain unclear [10].  Findings from our study suggest that even if an association with colorectal cancer does exist, 
digestible carbohydrates do not appear to be of etiological importance in the initiation stages of colorectal tumour 
development for either the traditional adenoma-carcinoma or serrated polyp pathways. 
 
Our analysis has several strengths, including adequate statistical power due to large size, the ability to account 
for other potential confounding, and thorough endoscopic investigation of participants at diagnosis minimising 
the potential for outcome misclassification.  One potential limitation of our analyses was the reduced statistical 
power in subgroup analyses conducted.  Further, it is possible that our method of dietary assessment was not 
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precise enough to detect an association between dietary carbohydrate intake and polyp risk, should one exist.  
This study was not able to assess glycemic index or glycemic load. As in all epidemiological case-control 
studies, there are potential limitations such as the possibility of selection bias, reverse causation or recall bias, 
whereby polyp cases may have altered their carbohydrate intake, or inadvertently contributed to dietary 
measurement error, resulting in falsely different intakes compared with controls.  However, this is unlikely 
given the benign nature of colorectal polyps, and considering previous analyses of other dietary and lifestyle 
factors within this population (13) has been able to detect associations with adenoma and/or hyperplastic polyp 
risk.  
 
In conclusion, results from our large US population-based study do not suggest an etiological role for dietary 
carbohydrate in early colorectal metaplastic or dysplastic changes.  
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Table 1. Descriptive characteristics of individuals in the Tennessee Colorectal Polyp Study, 2003-2010. 
  Polyp type  
 Controls Adenoma 
only
Hyperplastic 
polyp only
Both b  
Characteristic a n= 3,184  n= 1,315 n= 566  n= 394 P-value 
Study site 
  Vanderbilt University Medical Center 
  VA, Tennessee Valley Health System 
 
2,441 (76.7) 
743    (23.3) 
 
928    (70.6) 
387    (29.4) 
 
360 (63.6) 
206 (36.4) 
 
226 (57.4) 
168 (42.6) 
 
 
<0.001 
Reason for colonoscopy 
  Screening 
  Family history 
  Diagnostic/symptomatic/follow-up 
  Other 
 
1,838 (57.7) 
421    (13.2) 
671    (21.1) 
254    (8.0) 
 
786    (59.8) 
148    (11.3) 
275    (20.9) 
106    (8.1) 
 
321 (56.7) 
73   (12.9) 
114 (20.1) 
58   (10.3) 
 
216 (54.8) 
52   (13.2) 
73   (18.5) 
53   (13.5) 
 
 
 
 
0.02 
Age, years  57.5 ± 7.6 59.2 ± 7.6 57.5 ± 7.0 58.8 ± 6.9 <0.001 
Sex,  Male 1,733 (54.4) 913    (69.4) 378 (66.8) 302 (76.7) <0.001 
Educational attainment 
  High school or less  
  Some college 
  College graduate  
  Graduate or professional education 
 
689    (21.7) 
875    (27.6) 
710    (22.4) 
897    (28.3) 
 
376    (28.7) 
330    (25.2) 
296    (22.6) 
308    (23.5) 
 
167 (29.7) 
165 (29.4) 
117 (20.8) 
113 (20.1) 
 
146 (37.1) 
136 (34.5) 
60   (15.2) 
52   (13.2) 
 
 
 
 
<0.001 
Race, White 2,928 (92.0) 1,179 (89.7) 520 (91.9) 367 (93.2) 0.04 
Family history of colorectal cancer 9.1 9.8 8.5 11.3 0.10 c 
BMI, kg/m2 27.3 27.8 28.0 28.3 <0.001 c 
Height, m 1.71 1.72 1.72 1.72 0.05 c 
Smoking status 
  Never 
  Former 
  Current 
 
55.1 
34.6 
10.3 
 
48.8 
32.7 
18.5 
 
32.7 
39.5 
27.9 
 
26.8 
30.8 
42.4 
 
 
 
<0.001 c 
Alcohol consumption status 
  Never 
  Former 
  Current 
 
60.5     
19.8 
19.7 
 
57.0 
22.2 
20.8 
 
54.4 
22.9 
22.8 
 
55.8 
23.9 
20.3 
 
 
 
0.01 c 
Regular exercised in past 10 years 58.8 54.6 52.9 47.5 <0.001 c 
Ever NSAID Use 51.5 45.7 52.2 49.2 0.009 c 
Ever Multivitamin Use 55.9 47.3 50.5 47.4 <0.001 c 
Ever HRT Use (women only) 62.0 59.2 61.5 57.4 0.49 c 
Postmenopausal (women only) 73.8 73.3 78.2 86.3 0.02 c 
Daily nutrient intakes      
  Total energy (kcal) 1862 1930 1923 1929 0.02 c 
  Red meat (g) 44.0 52.0 55.1 60.5 <0.001 c 
  Total carbohydrate (g/1000kcal) 124.4 123.2 121.8 120.0 <0.001 d 
  Available carbohydrate (g/1000kcal) 114.7 113.9 112.6 111.3 0.006 d  
  Total sugars (g/1000kcal) 59.5 59.0 57.3 57.7 0.06 d
  Starch (g/1000kcal) 55.1 54.9 55.3 53.6 0.10 d 
  Dietary fiber (g/1000kcal) 9.8  9.3 9.2 8.7 <0.001 d 
  Dietary calcium (mg/1000kcal) 479.9 454.8 448.4 445.7 <0.001 d 
  Dietary folate equivalents (µg/1000kcal) 320.0 305.3 298.0 291.1 <0.001 d 
 
BMI: Body mass index; HRT: Hormone Replacement Therapy; NSAID: Non-steroidal anti-inflammatory drug; VA: 
Veterans Affairs. 
a Categorical data presented as n (%), continuous data presented as mean ± SD. 
b Synchronous adenomas and hyperplastic polyps. 
c P-values adjusted for age (5-year categories) and sex. Data presented as least square mean of log transformed data 
(continuous) or frequencies standardized to age (5-year categories) and sex distribution of controls.  
d P-values adjusted for age (5-year categories), sex and energy intake.  Data presented as least square mean of log 
transformed data (continuous) or frequencies standardized to age (5-year categories) and sex distribution of controls.
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Table 2. Aspects of dietary carbohydrate intake and colorectal polyp risk in the Tennessee Colorectal Polyp Study, 2003-2010. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a Adjusted for energy intake (residuals method and entering log kcal/day into the model), age, sex, study site (Vanderbilt University Medical Centre/VA Tennessee Valley 
Health System), colonoscopy indication (screening/family history/symptomatic/other), race (White/other), BMI (kg/m2), smoking status (never/former/current), alcohol 
consumption (never/former/current), exercise (regular exercise in past 10 years), energy-adjusted dietary calcium intake (mg/d), dietary folate equivalents and red meat 
intake(g/d). 
b We had 80% statistical power to detect a significant inverse/direct association in the magnitude of OR 0.80/ OR 1.23 for adenoma only analysis, OR 0.73/ OR1.33 for 
hyperplastic polyp only analysis, and  OR 0.69/ OR 1.43 for both polyp types analysis. 
 
    Polyp type  
 
 
Controls Adenoma 
only 
Adjusted a,b 
OR (95% CI) 
Hyperplastic 
polyp only 
Adjusted a,b 
OR (95% CI) 
Both Adjusted a,b 
OR (95% CI) 
Daily nutrient intake  categories n (%) n (%)  n (%)  n (%)  
Total carbohydrate  
  Quartile 1 
  Quartile 2 
  Quartile 3 
  Quartile 4 
  P for trend 
 
796 (25.0) 
796 (25.0) 
796 (25.0) 
796 (25.0) 
 
362 (27.5) 
347 (26.4) 
309 (23.5) 
297 (22.6) 
 
1.00 
1.09 (0.90-1.32) 
1.03 (0.84-1.27) 
1.02 (0.82-1.27) 
0.99 
 
161 (28.5) 
164 (29.0) 
134 (23.7) 
107 (18.9) 
 
1.00 
1.25 (0.95-1.57) 
1.13 (0.85-1.50) 
1.02 (0.74-1.40) 
0.99 
 
133 (33.8) 
119 (30.2) 
71   (18.0) 
71   (18.0) 
 
1.00 
1.13 (0.84-1.52) 
0.75 (0.53-1.07) 
0.94 (0.64-1.36) 
0.32 
Available carbohydrate  
  Quartile 1 
  Quartile 2 
  Quartile 3 
  Quartile 4 
  P for trend 
 
796 (25.0) 
796 (25.0) 
796 (25.0) 
796 (25.0) 
 
359 (27.3) 
345 (26.2) 
306 (23.3) 
305 (23.2) 
 
1.00 
1.12 (0.92-1.35) 
1.03 (0.84-1.26) 
1.06 (0.86-1.32) 
0.80 
 
155 (27.4) 
167 (29.5) 
124 (21.9) 
120 (21.2) 
 
1.00 
1.35 (1.04-1.75) 
1.10 (0.83-1.47) 
1.18 (0.87-1.60) 
0.55 
 
126 (32.0) 
114 (28.9) 
80   (20.3) 
74   (18.8) 
 
1.00 
1.14 (0.85-1.55) 
0.88 (0.63-1.24) 
1.01 (0.70-1.46) 
0.71 
Total sugars  
  Quartile 1 
  Quartile 2 
  Quartile 3 
  Quartile 4 
   P for trend 
 
796 (25.0) 
796 (25.0) 
796 (25.0) 
796 (25.0) 
 
382 (29.1) 
312 (23.7) 
312 (23.7) 
309 (23.5) 
 
1.00 
0.96 (0.79-1.16) 
1.07 (0.87-1.30) 
1.03 (0.84-1.26) 
0.57 
 
173 (30.6) 
152 (26.9) 
124 (21.9) 
117 (20.7) 
 
1.00 
1.12 (0.87-1.44) 
1.02 (0.77-1.34) 
0.97 (0.73-1.30) 
0.75 
 
129 (32.7) 
101 (25.6) 
87   (22.1) 
77   (19.5) 
 
1.00 
1.07 (0.79-1.46) 
1.10 (0.79-1.53) 
1.00 (0.70-1.41) 
0.92 
Starch    
  Quartile 1 
  Quartile 2 
  Quartile 3 
  Quartile 4 
   P for trend 
 
796 (25.0) 
796 (25.0) 
796 (25.0) 
796 (25.0) 
 
327 (24.9) 
303 (23.0) 
346 (26.3) 
339 (25.8) 
 
1.00 
0.89 (0.74-1.08) 
1.04 (0.86-1.27) 
1.01 (0.81-1.26) 
0.58 
 
136 (24.0) 
136 (24.0) 
148 (26.2) 
146 (25.8) 
 
1.00 
1.01 (0.77-1.33) 
1.12 (0.84-1.48) 
1.18 (0.87-1.60) 
0.24 
 
97   (24.6) 
115 (29.2) 
110 (27.9) 
72   (18.3) 
 
1.00 
1.12 (0.82-1.54) 
1.08 (0.77-1.51) 
0.73 (0.49-1.08) 
0.15 
